Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amicus Therapeutics (FOLD)

10.66   -0.51 (-4.57%) 03-03 17:02
Open: 11.205 Pre. Close: 11.17
High: 11.28 Low: 10.64
Volume: 4,541,571 Market Cap: 2,794M
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.304 - 11.372 11.372 - 11.422
Low: 10.484 - 10.57 10.57 - 10.635
Close: 10.547 - 10.674 10.674 - 10.769

Technical analysis

as of: 2021-03-03 4:40:15 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 19.96     One year: 24.61
Support: Support1: 10.64    Support2: 8.85
Resistance: Resistance1: 17.09    Resistance2: 21.07
Pivot: 12.84
Moving Average: MA(5): 11.56     MA(20): 14.60
MA(100): 19.79     MA(250): 15.62
MACD: MACD(12,26): -2.42     Signal(9): -2.33
Stochastic oscillator: %K(14,3): 2.17     %D(3): 5.00
RSI: RSI(14): 19.70
52-week: High: 25.39  Low: 6.25  Change(%): 7.8
Average Vol(K): 3-Month: 398218  10-Days: 531310

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
FOLD has closed above bottom band by 28.3%. Bollinger Bands are 101.8% wider than normal. The large width of the bands suggest high volatility as compared to FOLD's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

Wed, 03 Mar 2021
Amicus Therapeutics' (FOLD) Buy Rating Reiterated at Robert W. Baird - MarketBeat

Tue, 02 Mar 2021
Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript - Motley Fool

Mon, 01 Mar 2021
Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 01 Mar 2021
Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq

Mon, 01 Mar 2021
Amicus Therapeutics: Q4 Earnings Insights - Yahoo Finance

Mon, 01 Mar 2021
Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 261
Shares Float (M) 210
% Held by Insiders 0.56
% Held by Institutions 108.02
Shares Short (K) 27,250
Shares Short P. Month (K) 33,120

Stock Financials

EPS -1.150
EPS Est This Year -1.320
EPS Est Next Year -1.020
Book Value (p.s.) 1.230
Profit Margin -120.18
Operating Margin -109.06
Return on Assets (ttm) -18.8
Return on Equity (ttm) -68.0
Qtrly Rev. Growth 38.3
Gross Profit (p.s.) 0.615
Sales Per Share 0.943
EBITDA (p.s.) -0.977
Qtrly Earnings Growth
Operating Cash Flow (M) -241
Levered Free Cash Flow (M) -123

Stock Valuations

PE Ratio -9.27
PEG Ratio
Price to Book value 8.67
Price to Sales 11.31
Price to Cash Flow -11.51

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.